Evidence map›Paper›PMID 38394060›Full record

Observational studyPloS one2024

Tau and Aβ42 in lavage fluid of pneumonia patients are associated with end-organ dysfunction: A prospective exploratory study.

Phoibe Renema, Jean-Francois Pittet, Angela P Brandon, Sixto M Leal, Steven Gu, Grace Promer, Andrew Hackney, Phillip Braswell, Andrew Pickering, Grace Rafield and 9 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Lung endothelial cytopathic tau is sufficient to impair long-term potentiation during infection.American journal of respiratory cell and molecular biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Peripheral proteinopathy in neurodegenerative diseases.Translational neurodegeneration · 2025
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Phoibe RenemaCenter for Lung Biology, University of South Alabama, Mobile, Alabama, United States of America.
Jean-Francois PittetDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID 0000-0002-2196-9289
Angela P BrandonDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Sixto M LealDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Steven GuDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Grace PromerDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Andrew HackneyDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Phillip BraswellDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Andrew PickeringDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Grace RafieldDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Sarah VothDepartment of Cell Biology and Physiology, Edward Via College of Osteopathic Medicine, Monroe, Louisiana, United States of America.ORCID 0000-0003-3796-7154
Ron BalczonCenter for Lung Biology, University of South Alabama, Mobile, Alabama, United States of America.
Mike T LinCenter for Lung Biology, University of South Alabama, Mobile, Alabama, United States of America.
K Adam MorrowDepartment of Cell Biology and Physiology, Edward Via College of Osteopathic Medicine, Monroe, Louisiana, United States of America.
Jessica BellCenter for Lung Biology, University of South Alabama, Mobile, Alabama, United States of America.
Jonathon P AudiaCenter for Lung Biology, University of South Alabama, Mobile, Alabama, United States of America.
Diego AlvarezDepartment of Physiology and Pharmacology, Sam Houston State University, Conroe, Texas, United States of America.ORCID 0000-0001-8244-629X
Troy StevensCenter for Lung Biology, University of South Alabama, Mobile, Alabama, United States of America.
Brant M WagenerDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID 0000-0001-7889-1526
University of Alabama at Birmingham · USUniversity of South Alabama · USEdward Via College of Osteopathic Medicine · USSam Houston State University · US

Funding

T-type Calcium Channels and von Willebrand Factor ReleaseP01HL066299 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI STEVENS, TROY · 2001 to 2022
$34.6M
Training Translational Lung Biology and PathobiologyT32HL007778 · NHLBI · YALE UNIVERSITY · PI Erica L Herzog, NAFTALI KAMINSKI · 1994 to 2026
$14.4M
Nosocomial pneumonias impair cognitive functionR01HL140182 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI Mike Lin · 2018 to 2026
$4.9M
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal ImmunityR01AI170719 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Sixto Manuel Leal · 2023 to 2026
$2.9M
Caspase-1, the Microvascular Endothelium, and InfectionR01HL118334 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI ALVAREZ, DIEGO F., AUDIA, JONATHON PETER · 2015 to 2019
$2.0M
The Role of Sex Dimorphism in Post-TBI Bacterial PneumoniaR01GM127584 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WAGENER, BRANT M · 2018 to 2022
$1.9M
Soluble adenylyl cyclases in lung endothelial tauopathyR01HL167997 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI Troy Stevens · 2023 to 2026
$1.9M
Lung Endothelial Aß in infectious proteinopathyR01HL148069 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI STEVENS, TROY · 2020 to 2023
$1.5M
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal ImmunityR56AI170719 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEAL, SIXTO MANUEL · 2022 to 2022
$668k
Cytotoxic Lung Endothelial AmyloidsF31HL147512 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI VOTH, SARAH B. · 2019 to 2020
$38k
NHLBI NIH HHS F31 HL147512NHLBI NIH HHS P01 HL066299NHLBI NIH HHS R01 HL118334NHLBI NIH HHS R01 HL140182NHLBI NIH HHS R01 HL148069NHLBI NIH HHS R01 HL167997NHLBI NIH HHS T32 HL007778NIAID NIH HHS R01 AI170719NIAID NIH HHS R56 AI170719NIGMS NIH HHS R01 GM127584
6 · The paper itself

Abstract

backgroundBacterial pneumonia and sepsis are both common causes of end-organ dysfunction, especially in immunocompromised and critically ill patients. Pre-clinical data demonstrate that bacterial pneumonia and sepsis elicit the production of cytotoxic tau and amyloids from pulmonary endothelial cells, which cause lung and brain injury in naïve animal subjects, independent of the primary infection. The contribution of infection-elicited cytotoxic tau and amyloids to end-organ dysfunction has not been examined in the clinical setting. We hypothesized that cytotoxic tau and amyloids are present in the bronchoalveolar lavage fluid of critically ill patients with bacterial pneumonia and that these tau/amyloids are associated with end-organ dysfunction.

methodsBacterial culture-positive and culture-negative mechanically ventilated patients were recruited into a prospective, exploratory observational study. Levels of tau and Aβ42 in, and cytotoxicity of, the bronchoalveolar lavage fluid were measured. Cytotoxic tau and amyloid concentrations were examined in comparison with patient clinical characteristics, including measures of end-organ dysfunction.

resultsTau and Aβ42 were increased in culture-positive patients (n = 49) compared to culture-negative patients (n = 50), independent of the causative bacterial organism. The mean age of patients was 52.1 ± 16.72 years old in the culture-positive group and 52.78 ± 18.18 years old in the culture-negative group. Males comprised 65.3% of the culture-positive group and 56% of the culture-negative group. Caucasian culture-positive patients had increased tau, boiled tau, and Aβ42 compared to both Caucasian and minority culture-negative patients. The increase in cytotoxins was most evident in males of all ages, and their presence was associated with end-organ dysfunction.

conclusionsBacterial infection promotes the generation of cytotoxic tau and Aβ42 within the lung, and these cytotoxins contribute to end-organ dysfunction among critically ill patients. This work illuminates an unappreciated mechanism of injury in critical illness.

Indexed as

Pneumonia, BacterialSepsisAdultAgedAmyloidAmyloid beta-PeptidesAnimalsBronchoalveolar Lavage FluidCritical IllnessCytotoxinsEndothelial CellsFemaleHumansMaleMiddle AgedMultiple Organ FailureAmyloidAmyloid beta-PeptidesCytotoxinstau Proteins

Identifiers

PMID38394060
PMCPMC10889620
OpenAlexW4392097022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.